Clinical Note: While medication provides a biological mute button, a 2025 systematic review notes that these tools work best as a support to existing additions like therapy and nutritional support
As cells highly active in the homeostasis of the CNS microenvironment, astrocytes have already been shown to contribute to the pathophysiology of neuroinflammatory and neurodegenerative disorders, such as Alzheimers (85) and Parkinsons diseases (86)
Whether youre leaning toward an in-person consultation or the ease of an online prescription, San Francisco offers a variety of options to help you get started
Saxenda (liraglutide) is a GLP-1 receptor agonist licensed for weight management in adults with obesity or overweight with related conditions The medication has no established direct effect on sex hormone regulation or the reproductive system Weight loss itself can influence menstrual patterns and potentially cause changes in bleeding, independent of medication Any unexplained vaginal bleeding requires medical assessment to exclude pregnancy, infection, structural abnormalities, or other underlying causes Postmenopausal bleeding or persistent intermenstrual bleeding warrants urgent referral according to NICE guidance Table of Contents Understanding Saxenda and Potential Side Effects Saxenda (liraglutide 3.0 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related health conditions such as type 2 diabetes, hypertension, or dyslipidaemia
